Anemia, Iron-Deficiency

• 

  Subject Areas on Research

  • A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. 
  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. 
  • Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. 
  • An assessment of medical resource utilization and hospitalization cost associated with a diagnosis of anemia in women with obstetrical bleeding in the United States. 
  • Anemia and coronary artery disease: pathophysiology, prognosis, and treatment. 
  • Cases from the Osler Medical Service at Johns Hopkins University. Diffuse colonic angiodysplasia with chronic iron deficiency anemia. 
  • Caught on Capsule: Iron-deficiency Anemia Due to Hookworm Infection. 
  • Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates. 
  • Disorders of iron metabolism. 
  • Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. 
  • Efficacy of iron-supplement bars to reduce anemia in urban Indian women: a cluster-randomized controlled trial. 
  • Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. 
  • Hair Mercury Level is Associated with Anemia and Micronutrient Status in Children Living Near Artisanal and Small-Scale Gold Mining in the Peruvian Amazon. 
  • Health, nutrition and prosperity: a microeconomic perspective. 
  • Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. 
  • Household food insecurity is a risk factor for iron-deficiency anaemia in a multi-ethnic, low-income sample of infants and toddlers. 
  • Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. 
  • Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron. 
  • Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. 
  • Iron deficiency in young Lebanese children: association with elevated blood lead levels. 
  • Iron deficiency: lessons from anemic mice. 
  • Iron deprivation in cancer--potential therapeutic implications. 
  • Iron metabolism: iron deficiency and iron overload. 
  • Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). 
  • Nutrition and hearing loss: a neglected cause and global health burden. 
  • Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure. 
  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. 
  • Prevalence of iron deficiency in children with Down syndrome. 
  • Proinflammatory state, hepcidin, and anemia in older persons. 
  • Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design. 
  • The association between serum copper and anaemia in the adult Second National Health and Nutrition Examination Survey (NHANES II) population. 
  • The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic. 
  • Treatment of iron deficiency anemia: are monomeric iron compounds suitable for parenteral administration?